Does rosiglitazone alleviate the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts?
Rosiglitazone may alleviate the extent of fibrosis in dcSSc.
Both Cani and Cyno were readily killed by human whole blood and serum in a complement-dependent way. Thus, it is not likely that serum bactericidal capacity is the key determinant for the clinical outcome in Cani or Cyno-infections.